From Liver Injury to Hepatobiliary Cancer: Mechanisms, Metabolic Inflammation, and Clinical Evolution in the Post-DAA Era
Contents
Chair
Giuliano Ramadori, MD
Professor of medicine, Gastroenterology and Endocrinology, University Medical Center Göttingen, Göttingen, Germany;
Executive Chief Editor of Hepatoma Research.
Executive Chief Editor of Hepatoma Research.
Speaker(s)
Silvia Gaia, MD
Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
Topic: Has the clinical profile of patients with hepatocellular carcinoma evolved in the post–HCV eradication era following the introduction of direct-acting antiviral (DAA) therapy?
Topic: Has the clinical profile of patients with hepatocellular carcinoma evolved in the post–HCV eradication era following the introduction of direct-acting antiviral (DAA) therapy?
Gian Paolo Caviglia, PhD
University of Turin, Turin, Italy
Topic: HCC after DAA treatment
Topic: HCC after DAA treatment
Marina Serra, PhD
University of Cagliari, Cagliari, Italy
Topic: Experimental Models of HCC
Topic: Experimental Models of HCC
Diego F Calvisi, MD, PhD
University of Regensburg, Regensburg, Germany
Topic: Mouse Models of Cholangiocarcinoma
Topic: Mouse Models of Cholangiocarcinoma
Programme
Programme
| Time (CET) | Sessions | Speakers | Topics |
|---|---|---|---|
| 14:00-14:15 | Opening Keynote | Prof. Giuliano Ramadori | What makes the Liver Cancer Development Process so Special? |
| 14:15-14:35 | Clinical Evolution I | Dr. Silvia Gaia | Has the clinical profile of patients with hepatocellular carcinoma evolved in the post-HCV eradication era following the introduction of direct-acting antiviral (DAA) therapy? |
| 14:35-14:55 | Clinical Evolution II | Dr. Gian Paolo Caviglia | HCC after DAA treatment |
| 14:55-15:25 | Experimental & Mechanistic Insights | Dr. Marina Serra | Experimental Models of HCC |
| 15:25-15:55 | Expanding the Spectrum | Prof. Diego F. Calvisi | Mouse Models of Cholangiocarcinoma |
| 15:55-16:05 | Discussion | All speakers | How do liver injury and regeneration intersect with metabolic inflammation to shape hepatobiliary cancer risk in the post-viral era? |
| 16:05-16:10 | Summary | Prof. Giuliano Ramadori | / |
